News: Biotech

Here are your up-to-date news results!
Clicking the title of the article will give you the original publication.
You can share an article quickly with colleagues via Twitter and LinkedIn!

Cerecor to Acquire Aevi Genomic Medicine
Published: 5 Dec 2019 | 0:00 UTC

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan and rare diseases, as well as neurology announced today it has entered into a definitive merger agreement to acquire Aevi Genomic Medicine

GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain
Published: 5 Dec 2019 | 0:00 UTC

This transaction will significantly reduce the Company's operating expenses, generate near-term working capital, and provide ongoing cashflow to enable the Company to focus solely on its biopharmaceutical and wellness assets.

Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating Alzheimer’s with Cannabis
Published: 5 Dec 2019 | 0:00 UTC

The study will encompass patient surveys, memory tests, caregiver surveys, brain scans, and blood tests.

Movement Industries Corp. (OTC: MVNT) Completes Acquisition of SGX Industrial LLC
Published: 5 Dec 2019 | 0:00 UTC

Movement Industries Corp. (OTC PINK: MVNT) announced today that the company has completed the acquisition of SGX Industrial LLC.

Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries
Published: 5 Dec 2019 | 0:00 UTC

The transaction is subject to customary closing conditions and expected to be finalized by mid-December.

Centene and WellCare Receive State Approvals for Pending Merger from Illinois and New Jersey
Published: 5 Dec 2019 | 0:00 UTC

All 27 States Have Provided Approvals of Centene's Control of WellCare Domestic Insurers

More batches of common hypertension drug taken off the market
Published: 27 Sep 2019 | 11:00 UTC

Torrent Pharmaceuticals Ltd. is withdrawing more batches of Losartan potassium tablets, USP and Losartan potassium/hydrochlorothiazide tablets, USP.

New drug relieves acute migraine in clinical trial
Published: 12 Jul 2019 | 16:00 UTC

The results of a large phase III trial show that the novel drug rimegepant can relieve pain and other symptoms of acute migraine with minimal side effects.

Switching off this enzyme reversed prediabetes in mice
Published: 9 Jul 2019 | 17:00 UTC

A new study shows that deactivating an enzyme that alters ceramides can prevent insulin resistance and fatty liver as well as reverse prediabetes in mice.

How vitamin D helps fight treatment-resistant cancer
Published: 19 Jun 2019 | 17:00 UTC

Two active forms of vitamin D can kill treatment-resistant cancer cells by blocking a way that the cells pump out chemotherapy drugs, a new study shows.

Why scientists are searching the ocean for new drugs
Published: 8 Jun 2019 | 8:00 UTC

Medical researchers are increasingly turning their attention to the ocean in their search for new drugs. In this Spotlight, we ask why.

What are the side effects and risks of Ritalin?
Published: 31 May 2019 | 2:00 UTC

Ritalin (methylphenidate) is a stimulant medication for the treatment of ADHD and narcolepsy. Ritalin can cause side effects and has the potential for misuse and addiction. Researchers are investigating the long-term safety and effectiveness of this drug in children and adolescents. Learn more here.

Please note that GR Consulting can not alter or influence the messages displayed, nor is it responsible for its content. If needed or desired, please refer to the original message and/or its originator.